| Budget Amount *help |
¥3,770,000 (Direct Cost: ¥2,900,000、Indirect Cost: ¥870,000)
Fiscal Year 2011: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
Fiscal Year 2010: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2009: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
|
|---|
| Research Abstract |
I released a paper reporting novel lipd biomarker of Hepatitis C, a disease highlighted because of its similarity with Non-Alcoholic Steato Hepatitis (NASH) from the viewpoint of fatty liver diseases (PLoS One. 2011 Feb 25 ; 6(2) : e17309.). And I have had a patent application on a novel NASH blood biomarker not only in Japan, but also internationally. I have also submitted a paper describing this novel NASH marker.
|
